По вашему запросу найдено документов: 307

Страница 1 из 31

Therapeutic drug monitoring (TDM) as intervention: A cross-sectional analysis of characteristics of 173 registered clinical trials
Zhao, Shanshan, Zaytseva, Olga, Zaytseva, Olga, Zhang, Boquan (2022)
Background: To examine fundamental characteristics of clinical trials with therapeutic drug
Systematic review: Pharmacological interventions for the treatment of post-stroke fatigue
Chu, Shuk Han, Zhao, Xu, Komber, Ahmad, Cheyne, Joshua, Wu, Simiao, Cowey, Eileen, Kutlubaev, Mansur, Mead, Gillian (2023)
reviews of randomized controlled trials found insufficient evidence to guide practice, but most excluded
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) FOR STROKE RECOVERY
LEGG, L.A., TILNEY, R., HSIEH, C.F., WU, S., LUNDSTRÖM, E., RUDBERG, A.S., KUTLUBAEV, M.A., DENNIS, M., MEAD, G.E., SOLEIMANI, B., BARUGH, A., HACKETT, M.L., HANKEY, G.J (2019)
in people who were not depressed at randomisation. A large trial of fluoxetine for stroke recovery
Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative
Rumyantsev, Alexey A., Tyulyandina, Alexandra S., Tryakin, Alexey A., Fedyanin, Mikhail Y., Tjulandin, Sergey A. (2023)
Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative
INTERVENTIONS FOR POST-STROKE FATIGUE
Wu, S., Kutlubaev, M.A., Chun, Ho-Yan Y, Cowey, E., Pollock, A., Macleod, M.R., Dennis, M., Keane, E., Sharpe, M., Mead, G.E (2015)
We retrieved 12,490 citations, obtained full texts for 58 studies and included 12 trials (three
FLUOXETINE FOR STROKE RECOVERY META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
MEAD, G.E., LEGG, L., TILNEY, R., HSIEH, C.F., WU, S., LUNDSTRÖM, E., RUDBERG, A.S., KUTLUBAEV, M., DENNIS, M.S., SOLEIMANI, B., BARUGH, A., HACKETT, M.L., HANKEY, G.J. (2020)
included databases, trials registers, reference lists, and contact with experts. Co-primary outcomes were
MiRNA regulated therapeutic potential of the stromal vascular fraction: Current clinical applications - A systematic review: SVF and miRNAs
Agaverdiev, Murad, Shamsov, Bedil, Mirzoev, Sorbon, Vardikyan, Andranik, Encarnacion, Manuel Ramirez, Nurmukhametov, Renat, Beilerli, Aferin, Zhang, Bohan, Gareev, Ilgiz, Pavlov, Valentin (2023)
into two stages. Results: By August 2022, there were 149 registered clinical trials. Most studies belong
Children with Growth Hormone Deficiency Treated with Lonapegsomatropin Demonstrated Sustained Height Improvements for up to 6 Years: enliGHten Trial Final Results
Maniatis, Aristides K., Thornton, Paul S., Nadgir, Ulhas M., Vlachopapadopoulou, Elpis, Malievskiy, Oleg, Aghajanova, Elena M., Korpal-Szczyrska, Maria, Woods, Katie A., Mao, Meng, Zhao, Carol, Abdelrahman, Sohair G., Huang, Eric A., Komirenko, Allison S., Shu, Aimee D., Shu, A.D., Hofman, Paul (2025)
Introduction: This international, Phase 3, open-label extension trial evaluated the long
Phase I/II trial of local interstitial chemotherapy with arsenic trioxide in patients with newly diagnosed glioma
Han, Dayong, Teng, Lei, Wang, Xiaoxiong, Zhen, Yunbo, Chen, Xiaofeng, Yang, Mingchun, Gao, Ming, Yang, Guang, Han, Mingyang, Wang, Ligang, Xu, Jiajun, Li, Yue, Shumadalova, Alina, Zhao, Shiguang (2022)
, and the dose recommended for a phase II trial is 1.5 mg. Copyright © 2022 Han, Teng, Wang, Zhen, Chen, Yang
Синтетические биоматериалы на основе гидроксиапатита и трикальцийфосфата: анализ текущих клинических испытаний
Synthetic biomaterials based on hydroxyapatite and tricalcium phosphate: analysis of current clinical trials
Mukhametov, U.F., Ivliev, D.S., Gareev, I.F., Lyulin, S.V., Borzunov, D.Yu., Мухаметов, У.Ф., Ивлиев, Д.С., Гареев, И.Ф., Люлин, С.В., Борзунов, Д.Ю. (2024)
clinical trials

Страница 1 из 31

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год